[Therapeutic trial in disseminated Hodgkin's disease (stages 3 and IV) by sequence chemotherapy, radiotherapy, eventually associated with splenectomy and supplementary chemotherapy].
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013156:Splenectomy; D014265:Triethylenemelamine / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D006834:Hydrazines; D014747:Vinblastine; D014265:Triethylenemelamine; D011241:Prednisone
Essai de traitement de la maladie de Hodgkin disséminée ou généralisée (stades 3 et IV) par la séquence chimiothérapie, radiothérapie, association éventuelle à splénectomie et chimiothérapie supplémentaire.